Faber J E, Gettes D R, Gianturco D P
Department of Physiology, University of North Carolina, Chapel Hill 27599-7545.
Circ Res. 1988 Aug;63(2):415-28. doi: 10.1161/01.res.63.2.415.
The cremaster skeletal muscle of anesthetized rats was denervated and extended with intact circulation into a tissue bath. Intravital microscopy was used to measure microvessel diameter at three different anatomical levels within the microcirculation: large distributing arterioles (x control diameter = 100 +/- 7 micron), large capacitance venules (147 +/- 8 micron), and small terminal arterioles (17 +/- 1 micron). Norepinephrine (NE) was added to the cremaster bath to produce intermediate reductions in diameter of large arterioles and venules (55% and 38% of maximum constriction, respectively). In the presence of NE tone, bath-added atrial natriuretic factor (ANF) produced concentration-dependent dilation of both arterioles and venules. Arteriolar IC25 = 18 pmol and IC50 = 1.2 X 10(-10) M; venules exhibited similar sensitivity. However, the highest ANF concentration examined (10(-7) M) only reversed NE-induced tone by 70%. In a second large vessel group ANF completely reversed constriction induced by the alpha 1-adrenoceptor agonist, phenylephrine, in the presence of 5 X 10(-7) M yohimbine. However, vessels constricted with the alpha 2-receptor agonist UK-14,304 (in the presence of 10(-8) M prazosin) were insensitive to ANF. A third group of terminal arterioles, which possess considerable spontaneous "intrinsic" tone, were studied in the absence of alpha-receptor agonists. Significant dilation occurred at greater than 10(-7) M, and the maximal response was only 25% of complete dilation with adenosine. These data indicate that ANF exhibits a high potency and selectivity for reversal of alpha 1-adrenoceptor-mediated constriction of large arterioles and venules. Constriction produced by alpha 2-adrenoceptor occupation or by nonadrenergic "intrinsic" mechanisms appears to be insensitive to ANF. We propose that the ability of ANF to reduce microvascular resistance depends on the relative contribution of alpha 1-, alpha 2-, and intrinsic vasoconstrictor components to the prevailing level of smooth muscle tone. Differences in these components among regional circulations and between arterial and venous smooth muscle may contribute to the systemic hemodynamic pattern produced by ANF.
对麻醉大鼠的提睾骨骼肌进行去神经处理,并在保持血液循环完整的情况下将其放入组织浴槽中。利用活体显微镜在微循环的三个不同解剖水平测量微血管直径:大的分布小动脉(对照直径(x = 100 ± 7)微米)、大的容量小静脉((147 ± 8)微米)和小的终末小动脉((17 ± 1)微米)。向提睾肌浴槽中加入去甲肾上腺素(NE),使大的小动脉和小静脉直径出现中度减小(分别为最大收缩的(55%)和(38%))。在存在NE张力的情况下,向浴槽中加入心房利钠因子(ANF)会使小动脉和小静脉都出现浓度依赖性扩张。小动脉的(IC25 = 18)皮摩尔,(IC50 = 1.2×10^{-10}) M;小静脉表现出相似的敏感性。然而,所检测的最高ANF浓度((10^{-7}) M)仅使NE诱导的张力逆转了(70%)。在第二个大血管组中,在存在(5×10^{-7}) M育亨宾的情况下,ANF完全逆转了由α1 - 肾上腺素能受体激动剂去氧肾上腺素诱导的收缩。然而,用α2 - 受体激动剂UK - 14,304收缩的血管(在存在(10^{-8}) M哌唑嗪的情况下)对ANF不敏感。在不存在α - 受体激动剂的情况下,对第三组具有相当大自发“内在”张力的终末小动脉进行了研究。在大于(10^{-7}) M时出现显著扩张,最大反应仅为腺苷完全扩张的(25%)。这些数据表明,ANF对逆转α1 - 肾上腺素能受体介导的大的小动脉和小静脉收缩具有高效能和选择性。由α2 - 肾上腺素能受体占据或非肾上腺素能“内在”机制产生的收缩似乎对ANF不敏感。我们提出,ANF降低微血管阻力的能力取决于α1 - 、α2 - 和内在血管收缩成分对平滑肌张力主导水平的相对贡献。区域循环之间以及动脉和静脉平滑肌之间这些成分的差异可能有助于ANF产生的全身血流动力学模式。